Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway
|更新时间:2024-07-12
|
Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway
“The latest research found that Danggui Buxue Decoction can effectively protect podocytes in diabetes nephropathy by inhibiting the PERK/ATF4/CHOP signaling pathway, providing a new strategy for treatment.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 16, Pages: 10-18(2024)
GU Yue,SHEN Yuhang,DING Xin,et al.Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):10-18.
GU Yue,SHEN Yuhang,DING Xin,et al.Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):10-18. DOI: 10.13422/j.cnki.syfjx.20240901.
Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway